Comparative activity of azithromycin against clinical isolates of mycobacteria

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 3, 1996, Pages 539-542

  Watt, B ^a   Rayner, A ^a   Harris, G ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM MARINUM;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; RADIOMETRY;

EID: 0029838799     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.3.539     Document Type: Article

References (11)

1. Bernard, E. M., Edwards, F. F., Kiehn T. E., Brown, S. T., & Armstrong, D. (1993). Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum. Antimicrobial Agents and Chemotherapy 37, 2323-6.
2. Bright, G. M., Nagel, A. A., Bordner, J., Desai, K. A., Dibrino, J. N., Nowakowska, J. et al. (1988). Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-AZA-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides. Journal of Antibiotics 41, 1029-47.
3. Girard, A. E., Girard, D., English, A. R., Gootz, T. D., Cimochowski, C. R., Faiella, J. A. et al. (1987). Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrobial Agents and Chemotherapy 31, 1948-54.
4. Heifets, L., Mor, N. & Vanderkolk, J. (1993). Mycobacterium avium strains resistant to clarithromycin and azithromycin. Antimicrobial Agents and Chemotherapy 37, 2364-70.
5. Inderlied, C. B., Kolonoski, P. T., Wu, M. & Young, L. S. (1989). In-vitro and in-vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex. Journal of Infectious Diseases 159, 994-7.
6. Klemens, S. P., & Cynamon, M. H. (1994). Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice. Antimicrobial Agents and Chemotherapy 38, 1455-9.
7. Naik, S. & Ruck, R. (1989). In-vitro activities of several new macrolide antibiotics against Mycobacterium avium complex. Antimicrobial Agents and Chemotherapy 33, 1614-6.
8. Panteix, G., Guillaumond, B., Harf, R., Desbos, A., Sapin, V., Leclercq, M. et al. (1993). In-vitro concentration of azithromycin in human phagocytic cells. Journal of Antimicrobial Chemotherapy 31, Suppl. E. 1-14.
9. Watt, B., Rayner, A. & Harris, G. (1993). Modern methods in mycobacteriology. Reviews in Medical Microbiology 4, 97-105.
10. Wise, R. (1994). The pharmacokinetics of azithromycin. Reviews in Contemporary Pharmacotherapy 5, 329-40.
11. Young, L. S., Wiviott, L., Wu, M., Kolonoski, P., Bolan, R. & Inderlied, C. B. (1993). Azithromycin for treatment of Mycobacterium avium - intracellulare complex in patients with AIDS. Lancet 338, 1107-9.